VeinBrain: The Future's Operating System for Vein Health
This pioneering phlebology technology will unleash unparalleled innovations in scientific analysis, transformative medical software, breakthrough AI solutions, and blockchain's untapped potential, yielding unprecedented returns.
Investment-Grade Innovations
Scalable Solutions, Real-World Impact. Our Product Suite Designed for Exponential Growth.

Patient Information Software
Digitally Empowering Healthcare: Partnering with industry-leading designers, programmers, SEO experts, and ethics specialists, we craft highly-targeted websites and marketing tools exclusively for medical professionals. A smart investment in patient-focused solutions.

Management Software
Intelligent Business Operations: Our custom-designed management software delivers real-time analytics for instant decision-making, revenue projections, and streamlined reports at the tap of a button. Perfect for stakeholders demanding immediate, actionable insights.

Artificial Intelligence Medical Software
The Future, Today: A.I.M® represents the pinnacle of AI in medical applications. Focused on research, diagnostics, and advanced therapies, it's where human brilliance and machine intelligence synergize for peak performance. A breakthrough investment opportunity.

Google Customer Satisfaction Software
Optimizing the Search Experience: Designed for the sprawling community of Google users, our software aims to redefine search satisfaction and user engagement. A game-changer for the Google ecosystem.

Medical Buisness Software
Operational Excellence, Optimized: Products like MED24 or CITO! provide clinics and healthcare facilities with the tools to sustain top-notch workflows, maximizing efficiency with a minimized staff. A scalable solution for an industry in flux.

Patient Information Printware
The Power of Tangibility: Our high-quality printed information complements our software offerings, catering to a diverse audience. Flexible formats available. Inquire for investor-friendly samples.
WHY VEINBRAIN?
Scalability:
Products engineered for exponential and succesfull growth.
Innovation:
Where scientific breakthrough meets market opportunity.
Profitability:
Custom solutions primed for generating unparalleled revenue streams.
Ready to Invest in Tomorrow, Today?
The New Horizon of Medical Tech Awaits
In a world obsessed with next-level innovation and data-driven solutions, VeinBrain stands as an indomitable force. Our curated selection of products isn’t just a portfolio; it’s a vision—a vision that embodies the future of healthcare, where cutting-edge technology meets human-centric design.
The Power of Intelligent Investment
Investors have the unique opportunity to be part of something revolutionary. We’re not just meeting industry demands; we’re preemptively creating solutions for challenges yet to be realized. And in this ever-evolving landscape, being ahead is the only way to ensure robust ROI and stakeholder satisfaction.
Don’t just invest in technology
Invest in the technology that’s setting the standards for tomorrow. Secure your stake in the future, and let VeinBrain guide you through the next era of medical and technological transformation.
Proven Expertise, Published Excellence
Global Thought Leaders in Data-Driven Medicine, Artificial Intelligence, and Cutting-Edge Blockchain Solutions

Unveiled in America's Medical Elite: The A.I.M® 434 Revelation
Featured in the JVS-VL Journal by the Society for Vascular Surgery and the American Venous Forum, this breakthrough study elevates artificial intelligence's role in medical science. Originally presented at the esteemed AVS in Orlando, FL.

December, 2021

Swiss Stamp of Approval: Our Debut in Vasa 2022
Endorsed by the iconic European Journal VASA, our pioneering work was showcased at the 2021 Swiss Society for Vascular Diseases meeting (USGG, Union der Schweizer Gesellschaften für Gefässmedizin).

March, 2022

First-of-its-Kind Innovation: A Milestone in A.I.M® 434 Research
Our groundbreaking full-text study on the artificial intelligence-based detection and developmental timeline of early venous insufficiency has been officially printed in the respected Egyptian Journal.

December, 2021
The VeinBrain Advantage:
A Beacon of Innovation and Opportunity
Engage with Our Team to delve deeper into our vision, our strategies, and the promising horizon that awaits.

In a world where the medical landscape is perpetually evolving, VeinBrain consistently emerges at the forefront of transformation. Our track record, exemplified through esteemed publications and research, signifies not just our past achievements but our vision for the future.
Credibility & Trustworthiness:
Our recognized work in leading global journals underscores our commitment to excellence. We’re not just contributors to medical advancements; we’re the pioneers leading the charge.
Growth Potential:
The intersection of AI, data-driven medicine, and blockchain presents vast potential for scalability and innovation. Our position at this juncture signifies a unique investment opportunity in an ever-expanding market.
Cutting-Edge Solutions:
With products like A.I.M® 434 and collaborations with prestigious medical societies, we have demonstrated our ability to turn ideas into actionable, market-ready solutions.
Invest in the Future of Medicine
We invite you, our potential partners and stakeholders, to be a part of this transformative journey. VeinBrain is more than a business; it’s a movement. A movement towards smarter, more efficient, and more effective medical solutions.
Join us in shaping the future. Discover the unparalleled potential of investing in VeinBrain, where your trust translates into tangible advancements for the world of medicine.
Unearth Unrivaled Returns in VeinCare Innovation
Join Us in Transforming a Multi-Billion Dollar Medical Market—Venartis® Is Revolutionizing Vein Care for the Next Generation
Rooted in Legacy, Pioneering the Future—That’s the DNA of VENARTIS®
Guided by the visionary work of Dr. Johann Christof Ragg, founder of the angioclinic® vein centers and a trailblazer in vascular research, VENARTIS® stands as a beacon in the phlebology universe. With a portfolio of high-impact projects and unparalleled expertise, we're your gateway to the rapidly evolving realm of minimally invasive and preventive vein therapy. As we advance the state of the art, there’s unprecedented opportunity for visionary investors to participate in monumental shifts within the sector—translating to substantial returns.
Why Invest in VENARTIS®?
Global Market Potential: We're not just targeting a niche; we're addressing a widespread, global health concern with life-changing technologies.
Innovative Edge: As pioneers in minimally invasive techniques and preventive care, we're setting new benchmarks for the entire industry.
Unmatched Expertise: Over 25 years of groundbreaking research and a trove of international patents make us the unrivaled leader in vein care solutions.
Get privileged access to in-depth information on how VENARTIS® is poised to disrupt multiple billion-dollar markets within the realm of vein therapy. Use the contact form below for tailored insights that matter to you.
Ready to Partner in Progress? We Are.
Unlock Access to Groundbreaking Phlebology Expertise with Venartis®
Your Gateway to Next-Gen Medical Solutions
In the fast-evolving realm of phlebology, we don't just adapt; we set the pace. Our continuously evolving suite of Venartis® solutions presents a wellspring of untapped opportunities for both corporate stakeholders and scientific communities. Eager to learn more? Our contact form is your portal to specialized insights.
The Venartis® Advantage
We're not just another medical technology company. As a strategically positioned holding company, our mission extends beyond the bounds of traditional phlebology. From groundbreaking medical products to health and nutrition offerings, quality certifications, and educational resources, we're redefining the landscape of venous medicine. Our scope also spans the full spectrum of modern digital technologies, presenting an integrated investment opportunity that's as expansive as it is lucrative.
Venartis AG
Chaltenbodenstrasse 16
CH - 8834 Schindellegi
Gem. Feusisberg (SZ)
Phone: +41 438 44 44 73
Email: info@venartis.com
UID: CHE-387.335.728
Company Register No.: HR01-1005013624
CEO
Karolina Pahlitzsch
MSL Manager
Margaryta Dittert
